The Future of Pharmacovigilance: Integrating AI with Drug Safety Systems

IQVIA's approach to AI in pharmacovigilance is centered on leveraging AI-enabled technologies throughout the drug development and manufacturing lifecycle. This white paper delves into the current regulatory landscape, emphasizing the FDA's ongoing efforts to provide guidance and clarity for AI integration in PV. It also outlines the critical steps organizations must take to align people, technology, and processes to build streamlined workflows supported by robust governance structures. Explore how AI-driven workflows can provide end-to-end services designed to address the most critical challenges in PV.

Download the white paper to gain deeper insights into how AI can revolutionize pharmacovigilance and drive innovation in drug safety systems.

Drug Safety and Pharmacovigilance

Harness the power of automation to execute streamlined end-to-end safety solutions while reducing costs.

Lifecycle Safety

Harness the power of global human expertise combined with automation, artificial intelligence (AI) and machine learning (ML) to design, build and execute end-to-end safety solutions.

Safety & Regulatory Compliance

Meet the challenge of changing stakeholder demands and increasing cost constraints with IQVIA's integrated technology services and analytics-driven offerings.

To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

Related solutions